title: The effects of anti-diabetic drugs on LDL subclasses: any role for colesevelam?
authors.affiliation: Biomedical Department of Internal Medicine and Medical Specialties, University of Palermo, Via del Vespro, 141, 90127, Palermo, Italy, mrizzo@unipa.it.
authors.forename: Manfredi
authors.initials: M
authors.lastname: Rizzo
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: Khalid
authors.initials: K
authors.lastname: Al-Rasadi
mesh_terms: D000499:Allylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069472:Colesevelam Hydrochloride; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male
chemical_list: D000924:Anticholesteremic Agents; D008074:Lipoproteins; D000499:Allylamine; D000069472:Colesevelam Hydrochloride